ReviewDiscover oncology2026
Application of Laser-Induced Breakdown Spectroscopy (LIBS) technology in malignant tumor diagnosis.
Review in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Laser-Induced Breakdown Spectroscopy (LIBS) represents a rapid analytical technique grounded in atomic emission spectroscopy, which has revealed considerable diagnostic capabilities within the biomedical sector in recent years. This review presents a comprehensive overview of the underlying principles, methodological advancements, clinical applications, and existing challenges related to LIBS technology in the detection of malignant tumors. By examining the disparities in elemental composition between tissue samples, LIBS proficiently distinguishes normal tissue from cancerous tissue, thereby providing valuable insights for the early detection of tumors, margin delineation, and treatment monitoring. The article further investigates the potential of amalgamating LIBS with other diagnostic modalities and deliberates on the future trajectories of this technology in translational medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.